Skin cancer remains one of the most common and rapidly increasing forms of cancer worldwide. Recent advances in nanotechnology have opened new opportunities for targeted cancer therapy, drug delivery systems, and molecular-level treatment strategies.This project focuses on investigating the interaction between selected nanomaterials and skin cancer-related proteins associated with the A-431 skin carcinoma cell line. The objective is to explore the potential therapeutic role of nanomaterials through computational analysis and molecular simulation approaches.The study involves the preparation and computational evaluation of six different nanomaterials against three target proteins relevant to skin cancer pathways.The workflow of the project includes multiple advanced computational techniques commonly used in drug discovery and nanomedicine research.Project Workflow:

1. Nanomaterial Preparation
   Six nanomaterials will be modeled and optimized using computational chemistry tools to ensure proper structural stability before biological interaction analysis.
2. Protein Selection and Preparation
   Three proteins related to skin cancer mechanisms in the A-431 cell line will be selected from protein databases and prepared for molecular docking studies.
3. Molecular Docking
   Docking simulations will be performed to evaluate binding affinity, interaction energy, and binding sites between the nanomaterials and the target proteins.
4. ADME Prediction
   Pharmacokinetic properties including absorption, distribution, metabolism, and excretion will be predicted to evaluate the potential biological compatibility of the studied nanomaterials.
5. Toxicity Assessment
   Computational toxicity analysis will be conducted to predict safety profiles and possible biological risks associated with each nanomaterial.
6. Density Functional Theory (DFT) Analysis
   Quantum chemical calculations will be performed to analyze electronic properties, stability, and reactivity of the nanomaterials.
7. Molecular Dynamics (MD) Simulation
   Molecular dynamics simulations will be used to evaluate the stability of the nanomaterial–protein complexes over time under physiological conditions.

Expected Outcomes:• Identification of promising nanomaterial candidates for skin cancer treatment research
• Detailed molecular interaction profiles
• Stability analysis of nanomaterial–protein complexes
• Comprehensive computational pharmacokinetic and toxicity evaluationThis project demonstrates how computational bioinformatics and nanotechnology can accelerate the discovery of potential therapeutic materials for cancer treatment while reducing laboratory costs and experimental time.